Fig. 2.

Serum levels of anti-MBP IgG antibodies shown in patients with chronic SCI and control subjects. Data are presented as a mean of nine (SCI) or eighteen (control) subjects and compared by two-factor ANOVA for repeated measures. *Indicates a statistically significant difference from control subjects (P < 0.05). The levels of IgG antibodies against MBP were significantly increased in patients with chronic SCI compared to healthy controls. SCI spinal cord injury, 1:x corresponds to ascendant dilutions